These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22344190)

  • 1. Clinical presentation, risk factors and treatment outcomes of first allograft rejection after penetrating keratoplasty in early and late postoperative period.
    Perera C; Jhanji V; Lamoureux E; Pollock G; Favilla I; Vajpayee RB
    Eye (Lond); 2012 May; 26(5):711-7. PubMed ID: 22344190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing outcomes of the treatment of allograft corneal rejection.
    Perera C; Jhanji V; Vajpayee RB
    Am J Ophthalmol; 2011 Sep; 152(3):358-363.e2. PubMed ID: 21683335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for corneal allograft rejection: intermediate results of a prospective normal-risk keratoplasty study.
    Küchle M; Cursiefen C; Nguyen NX; Langenbucher A; Seitz B; Wenkel H; Martus P; Naumann GO
    Graefes Arch Clin Exp Ophthalmol; 2002 Jul; 240(7):580-4. PubMed ID: 12136292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ten-year postoperative results of penetrating keratoplasty.
    Ing JJ; Ing HH; Nelson LR; Hodge DO; Bourne WM
    Ophthalmology; 1998 Oct; 105(10):1855-65. PubMed ID: 9787355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corneal endothelium and postoperative outcomes 15 years after penetrating keratoplasty.
    Patel SV; Hodge DO; Bourne WM
    Am J Ophthalmol; 2005 Feb; 139(2):311-9. PubMed ID: 15733993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep anterior lamellar keratoplasty using acellular corneal tissue for prevention of allograft rejection in high-risk corneas.
    Li J; Yu L; Deng Z; Wang L; Sun L; Ma H; Chen W
    Am J Ophthalmol; 2011 Nov; 152(5):762-70.e3. PubMed ID: 21803324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corneal endothelium and postoperative outcomes 15 years after penetrating keratoplasty.
    Patel SV; Hodge DO; Bourne WM
    Trans Am Ophthalmol Soc; 2004; 102():57-65; discussion 65-6. PubMed ID: 15747745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary findings in corneal allograft rejection in patients with keratoconus.
    Hargrave S; Chu Y; Mendelblatt D; Mayhew E; Niederkorn J
    Am J Ophthalmol; 2003 Apr; 135(4):452-60. PubMed ID: 12654360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic rejection of the central graft after limbal allograft transplantation combined with penetrating keratoplasty.
    Shimazaki J; Maruyama F; Shimmura S; Fujishima H; Tsubota K
    Cornea; 2001 Mar; 20(2):149-52. PubMed ID: 11248817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term rejection incidence and reversibility after penetrating and lamellar keratoplasty.
    Guilbert E; Bullet J; Sandali O; Basli E; Laroche L; Borderie VM
    Am J Ophthalmol; 2013 Mar; 155(3):560-569.e2. PubMed ID: 23218931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes after reversed corneal graft rejection: a report from the European VISICORT project.
    Iselin KC; Hjortdal J; Armitage WJ; Tole D; Pleyer U; Vabres B; Griffin MD; Murphy CC
    BMJ Open Ophthalmol; 2024 May; 9(1):. PubMed ID: 38772878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large-diameter penetrating keratoplasty: indications and outcomes.
    Skeens HM; Holland EJ
    Cornea; 2010 Mar; 29(3):296-301. PubMed ID: 20118782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Donor- and Recipient-Related Factors on Corneal Graft Survival in Penetrating Keratoplasty.
    Gediz F; Yüksel B; Küsbeci T; Akmaz O; Kartı Ö
    Semin Ophthalmol; 2019; 34(1):11-18. PubMed ID: 30496015
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term comparison of full-bed deep lamellar keratoplasty with penetrating keratoplasty in treating corneal leucoma caused by herpes simplex keratitis.
    Wu SQ; Zhou P; Zhang B; Qiu WY; Yao YF
    Am J Ophthalmol; 2012 Feb; 153(2):291-299.e2. PubMed ID: 21996306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-A, HLA-B and HLA-DR matching reduces the rate of corneal allograft rejection.
    Khaireddin R; Wachtlin J; Hopfenmüller W; Hoffmann F
    Graefes Arch Clin Exp Ophthalmol; 2003 Dec; 241(12):1020-8. PubMed ID: 14673570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interim results from the prospective "Erlanger Non-high-risk Penetrating Keratoplasty Study" in 207 patients].
    Graupner M; Seitz B; Langenbucher A; Martus P; Blüthner K; Nguyen NX; Wenkel H; Küchle M
    Klin Monbl Augenheilkd; 2000 Sep; 217(3):163-70. PubMed ID: 11076347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corneal graft rejection.
    Panda A; Vanathi M; Kumar A; Dash Y; Priya S
    Surv Ophthalmol; 2007; 52(4):375-96. PubMed ID: 17574064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for corneal graft failure and rejection in penetrating keratoplasty.
    Inoue K; Amano S; Oshika T; Tsuru T
    Acta Ophthalmol Scand; 2001 Jun; 79(3):251-5. PubMed ID: 11401633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graft rejection after Descemet's stripping automated endothelial keratoplasty: graft survival and endothelial cell loss.
    Li JY; Terry MA; Goshe J; Shamie N; Davis-Boozer D
    Ophthalmology; 2012 Jan; 119(1):90-4. PubMed ID: 22115709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penetrating keratoplasty in children.
    Aasuri MK; Garg P; Gokhle N; Gupta S
    Cornea; 2000 Mar; 19(2):140-4. PubMed ID: 10746443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.